CClinicalTrials.gg
Status unknownNCT05602922Updated Nov 2, 2022

Liu-Zi-Jue Exercise Combined With Conventional Rehabilitation Treat Dysphagia in Post-stroke

An interventional study of Liu-Zi-Jue Exercise and Basic treatment +Swallowing rehabilitation training in Stroke and Dysphagia, sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University. Status unknown at 1 site in China. Open to participants aged 30 Years to 85 Years. Per ClinicalTrials.gov, last updated 2022-11-02.

Sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2022, registered Sep 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
30 Years to 85 Years
Sex
All
01

Study summary

In this study, a prospective, randomized controlled method was adopted, with patients with post-stroke dysphagia as the main research objects, applying "Liu-Zi-Jue" to the patients for rehabilitation intervention, and to explore the effect of "Liu-Zi-Jue" on the swallowing function of patients with post-stroke dysphagia. In order to provide a safe and effective TCM treatment plan for patients with dysphagia after stroke, reduce the disability rate after stroke and improve the quality of life of patients.

Read the detailed description

This study is a single-center, prospective, randomized, controlled, clinical trial. A total of 60 inpatients with post-stroke dysphagia in the Third Affiliated Hospital of Zhejiang Chinese Medical University from April 2022 to December 2023 will be selected, and the patients will be assigned to the experimental group and the control group with 30 cases in each group according to the random number table. The control group will be given basic treatment and swallowing rehabilitation therapy, while the experimental group will be given Liu-Zi-Jue Exercise on the basis of the control group. Both groups are going to treat for 4 weeks and follow up for 60 days. Standardized Swallowing Assessment, Video Fluoroscopic Swallowing Study, Volume Viscosity Swallow Test, Penetration-aspiration scale, Water Swallow Test, Modified Barthel Index will be used to evaluate the swallowing function and living ability of patients, and to evaluate the clinical effect of Liu-Zi-Jue Exercise training on patients with dysphagia after stroke. Efficacy, clear its treatment advantages, in order to optimize the cost-effective and standardized rehabilitation program for dysphagia during stroke recovery, improve patients' swallowing function, improve their activities of daily living, and minimize the waste of health resources.

02

Conditions studied

  • Stroke
  • Dysphagia

Keywords

  • stroke
  • dysphagia
  • rehabilitation
  • Liu-Zi-Jue Exercise
03

In context

Deglutition Disorders

710 studies on the registry are indexed under Deglutition Disorders; 219 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 471 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

The Third Affiliated hospital of Zhejiang Chinese Medical University is the lead sponsor of 44 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

1.Meeting the diagnostic criteria of stroke in traditional Chinese medicine. 2.Meeting the diagnostic criteria of ischemic stroke in Western medicine. 3.Meeting the diagnostic criteria for swallowing disorders. 4.30 ≤ age ≤ 85 years; gender not restricted. 5.Duration of illness ≤ 180 days. 6.Water test at level 3 and above. 7.Voluntary participation in the subject, no serious complications, acceptable and good compliance with Liu-Zi-Jue Exercise treatment.

8.Sign the informed consent form.

Exclusion criteria

Exclusion Criteria:

  1. Patients with true bulbar palsy caused by brainstem encephalitis, motor neuron disease, pontine extension tumor, multiple sclerosis, myasthenia gravis, syringomyelia, etc.
  2. Cerebrovascular malformation, trauma, aneurysm, etc.
  3. Pregnant or lactating women.
  4. Patients with severe primary chronic diseases such as heart, liver, kidney and other organs, as well as endocrine system and hematopoietic system, severe dementia and cognitive impairment (Simple Mental State Scale Examination (MMSE): score \<15 points), severe language comprehension disorder, mentally ill patients.
  5. Patients with various bleeding tendency diseases.
  6. Patients who are allergic to swallowing contrast drugs.
  7. Patients who do not meet the inclusion criteria, do not have poor treatment compliance as prescribed, cannot judge the efficacy or have incomplete data, which affect the judgment of efficacy and are not suitable for clinical observation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    basic treatment+ swallowing rehabilitation treatment

    Swallowing function training mainly includes indirect training, direct training, and compensatory techniques, once a day for 20 minutes each time. In addition, a low-frequency electric VitalStim swallowing therapy device (produced by Chattanooga, USA) was also used for electrical stimulation therapy. The treatment parameters were 700ms in width, two-way square wave, 0~25mA in amplitude, and 30~80Hz in fixed frequency. The A electrode of channel 1 is placed above the hyoid bone, and the B electrode is placed above the notch on the thyroid cartilage. The channel 2 electrode C and electrode D of the therapeutic apparatus are arranged vertically and equidistantly according to the electrode A and electrode B. After the electrodes are placed, turn on the power. The stimulation intensity is based on the maximum stimulation that the patient can tolerate. 1 time a day, 30min each time, a total of 4 weeks.

    Other: Basic treatment +Swallowing rehabilitation training

  • Experimental
    basic treatment+ swallowing rehabilitation treatment+ Liu-Zi-Jue

    On the basis of the control group, the Liu-Zi-Jue exercises were performed, including "Xu, He, Hu, Si, Chui, Xi", 6 times each time, 5 times a week, each exercise for 30 minutes, and continuous treatment for 4 weeks.

    Combination Product: Liu-Zi-Jue Exercise

Interventions

  • Combination productLiu-Zi-Jue Exercise

    Combined with the actual situation of stroke patients, this Liu-Zi-Jue Exercise adopts the sitting position.

  • OtherBasic treatment +Swallowing rehabilitation training

    Basic treatment +Swallowing rehabilitation training

06

What researchers measure

Primary outcomes

  1. Rate of Change in Standardized Swallowing Assessment

    The scale consists of 3 parts, the first part includes the overall evaluation of the patient\&#39;s consciousness, lip closure control, head and trunk control, breathing pattern, soft palate movement, posterior function, gag reflex, spontaneous cough, etc., with a total of 8-23 points; Part 2: Let the patient drink 5ml of water, repeat 3 times, observe the water flow at the corners of the mouth when drinking water, laryngeal movement during swallowing, repeated swallowing, wheezing and laryngeal function, a total of 5 to 11 points; in the second part, if 2 or more times swallowing is normal Then carry out the third part of the assessment: the patient drinks 60 ml of water, and observes the drinking and swallowing, with a total of 5 to 12 points. The total score of this scale is 18-46 points, and the higher the score, the worse the swallowing function.

    Time frame: Baseline, 4 weeks and 60 days

Secondary outcomes

  1. Video fluoroscopic swallowing study

    The scale mainly includes three parts: oral stage, pharyngeal stage, and the degree of aspiration. The oral stage is 0-2 points; the pharyngeal stage is 0-3, and the degree of aspiration is 0-4. The total score is 9 points. The higher the value, the better the swallowing function.

    Time frame: Baseline and 4 weeks

  2. The volume viscosity swallow test

    The volume selected during the test is a small amount (5ml), a medium amount (10ml), a large amount (20ml), and the consistency is low consistency (water sample), medium consistency (thick paste), high consistency (pudding), according to different Combination, the complete test requires a total of 9 mouthfuls to eat, observe whether the patient coughs, whether the sound quality changes, and whether the blood oxygen saturation decreases to determine the patient\&#39;s swallowing safety, observe the patient\&#39;s lip closure, oral cavity residue, pharyngeal residue, and divided swallowing to determine the patient\&#39;s swallowing status Effectiveness to analyze the risk of swallowing and eating in patients.

    Time frame: Baseline and 4 weeks

  3. Penetration-aspiration scale

    The scale is divided into 3 categories and 8 grades according to whether the contrast agent enters the airway, the depth of entering the airway, and whether it can be discharged.

    Time frame: Baseline and 4 weeks

  4. Water swallow test

    The patient sits, drinks 30 ml of warm water, and is divided into 5 grades according to the time required and the condition of choking.

    Time frame: Before treatment, after 4 weeks of treatment and after 60 days of treatment.

  5. Modified Barthel Index

    The scale is scored by the patient\&#39;s ability to complete specific tasks in daily life, including grooming, eating, bathing, dressing, stool control, urination control, toilet use, bed and chair transfer, walking on level ground, and going up and down stairs with 10 items.

    Time frame: Baseline, 4 weeks and 60 days

07

Study locations

1 of 1 sites recruiting
  • The Third Affiliated hospital of Zhejiang Chinese Medical University
    Hangzhou, 浙江 310000, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05602922
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Responsible party
Ruijie Ma (Clinical Professor, The Third Affiliated hospital of Zhejiang Chinese Medical University) — Principal investigator
First posted
Nov 2, 2022
Start date
Apr 1, 2022
Primary completion
Dec 30, 2023 (estimated)
Completion
Dec 30, 2023 (estimated)
Last update
Nov 2, 2022

Study contacts

BEI QIU
Contact
1109476936@qq.com
15270855600
RUIJIE MA, Doctor
Contact
maria7878@sina.com
18057102851
RUJIE MA, Doctor
study director · The Third Affiliated hospital of Zhejiang Chinese Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion